Hans Nauwynck Selected Research

Viral Envelope Proteins

1/2021	Glyceraldehyde-3-Phosphate Dehydrogenase Restricted in Cytoplasmic Location by Viral GP5 Facilitates Porcine Reproductive and Respiratory Syndrome Virus Replication via Its Glycolytic Activity.
6/2011	Characterization of antigenic regions in the porcine reproductive and respiratory syndrome virus by the use of peptide-specific serum antibodies.
3/2006	Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans Nauwynck Research Topics

Disease

20	Infections 01/2022 - 05/2003
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2019
3	COVID-19 01/2022 - 01/2021
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 01/2021
2	Viremia 06/2019 - 03/2006
2	Pseudorabies 10/2013 - 03/2007
2	Necrosis 05/2003 - 07/2000
1	Disease Progression 07/2022
1	Carcinogenesis 07/2022
1	Human Influenza (Influenza) 01/2022
1	HIV Infections (HIV Infection) 01/2015
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2011
1	Respiratory Tract Infections (Respiratory Tract Infection) 08/2009
1	Body Weight (Weight, Body) 08/2009

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 01/2021 - 01/2012
4	Proteins (Proteins, Gene)FDA Link 11/2020 - 06/2011
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2019
3	Viral Envelope ProteinsIBA 01/2021 - 03/2006
3	CytokinesIBA 06/2019 - 05/2003
3	EnrofloxacinIBA 08/2009 - 06/2006
2	InterferonsIBA 01/2022 - 01/2014
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 06/2011
2	AntibodiesIBA 01/2019 - 06/2011
2	Drinking WaterIBA 08/2009 - 06/2006
2	florfenicolIBA 03/2007 - 06/2006
2	Amoxicillin (Wymox)FDA LinkGeneric 03/2007 - 06/2006
1	Oncogene Proteins (Oncogene Protein)IBA 07/2022
1	Bacterial ToxinsIBA 01/2022
1	ExotoxinsIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	NucleotidesIBA 11/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	WastewaterIBA 01/2021
1	Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA 01/2021
1	Therapeutic UsesIBA 11/2019
1	xanthohumolIBA 11/2019
1	AntigensIBA 06/2019
1	Interferon Type IIBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	Scavenger Receptors (Scavenger Receptor)IBA 10/2016
1	SAM Domain and HD Domain-Containing Protein 1IBA 01/2015
1	Virus ReceptorsIBA 01/2015
1	Small Interfering RNA (siRNA)IBA 01/2015
1	Interferon Regulatory FactorsIBA 01/2014
1	Protein Isoforms (Isoforms)IBA 01/2014
1	RNA (Ribonucleic Acid)IBA 01/2014
1	DNA VaccinesIBA 10/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2013
1	GP 4 (GP4)IBA 06/2011
1	Immune Sera (Antisera)IBA 06/2011
1	Immunologic Factors (Immunomodulators)IBA 06/2011
1	Dihydrotachysterol (AT 10)IBA 08/2009
1	Biological ProductsIBA 03/2007
1	lipopolysaccharide-binding proteinIBA 01/2005
1	Interleukin-10 (Interleukin 10)IBA 05/2003
1	InterleukinsIBA 05/2003
1	factor AIBA 07/2000
1	LipopolysaccharidesIBA 07/2000
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2000
1	Interleukin-1 (Interleukin 1)IBA 07/2000

Therapy/Procedure

2	Duration of Therapy 03/2007 - 06/2006
1	Personal Protective Equipment 01/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Therapeutics 11/2021
1	Anesthesia 01/2016